Halozyme Therapeutics Inc (HALO)

[Fred Kadiddlehopper]

Roche will publish its Sales Results for the 3rd Quarter of 2014 prior to the opening of the Swiss Stock Exchange on Thursday October 16th, 2014.
http://www.roche.com/investors/ir_update/inv-update-2014-09-16.htm
07:00 CEST / 06:00 BST / 01:00 AM EDT / 10:00 PM PDT (evening before)
Release will be e-mailed and posted on the Roche IR website click here.
Presentation slides will be posted on the Roche IR website click here.
We would like to invite all interested parties to dial in as outlined below:
14:00 – 15:15 CEST / 13:00 – 14:15 BST
08:00 – 09:15 AM EDT / 05:00 – 06:15 AM PDT

Conference call will start with presentations by senior management followed by a Q&A session (live access to the speakers).
Presenters:
Severin Schwan, CEO Roche Group
Alan Hippe, Chief Financial and IT Officer
Daniel O'Day, COO Pharmaceuticals
Roland Diggelmann, COO Diagnostics
To expedite the registration process on the day of the conference call, you may pre-register for the event by clicking here.
Alternatively you may dial in to the conference 10-15 min prior to the scheduled start , using the following numbers:
[phone] (Europe and ROW)
[phone] (UK)
[phone] (USA)
A live audio webcast can be accessed via ir.roche.com.
A replay of the conference call will be available one hour after the conference call, for 48 hours. Access is by dialing:
[phone] (Europe and ROW)
[phone] (UK)
[phone] (USA)
and will be asked to enter the ID 16780 followed by the # sign.
A replay of the webcast will be available on demand at ir.roche.com.
Best regards,
Karl Mahler
Head of Investor Relations